Mefenat ointment is used for topical treatment of the following inflammatory and necrotic ulcerative pathologies of the skin and mucous membranes: traumatic lip ulcers; carbuncles; exfoliative cheilitis; boils; traumatic skin wounds; chronic / acute ulcerative gingivitis; granulating wounds; long-term non-healing cracks; eczema; nonspecific oral ulcers; aphthous stomatitis; trophic ulcers; burn injuries.
active ingredients: mefenamine sodium salt, vinyline;
100 g of ointment contain mefenamine sodium salt in terms of dry matter 0.5 g, vinyline 10 g;
auxiliary substances: polyethylene glycol (400), emulsifier No. 1, purified water.
Pharmaceutical drug Mefenat, used to treat wounds, cracks and ulcerative lesions. This combination ointment contains a non-steroidal anti-inflammatory drug (NSAID) and an antimicrobial agent.
Mefenamine sodium salt is an NSAID. It has an anti-inflammatory effect, helps to suppress the proliferation of granulation tissue in the inflammation zone, while simultaneously stimulating regenerative processes. Also, this component of the ointment inhibits the development of allergic reactions, increases the level of local interferon and other cytokines, and has an analgesic effect for joint / muscle pain.
Vinylin has a bacteriostatic effect, promotes the activation of epithelialization processes, and accelerates wound healing.
The combination of these active ingredients enhances the analgesic, anti-inflammatory and wound healing effects of the ointment, as well as prolongs its effects. Also, the use of this ointment helps to increase the number of leukocytes in the wound and increase their phagocytic activity.
Mefenat ointment is used for topical treatment of the following inflammatory and necrotic ulcerative pathologies of the skin and mucous membranes:
- traumatic lip ulcers;
- exfoliative cheilitis;
- traumatic skin wounds;
- chronic / acute ulcerative gingivitis;
- granulating wounds;
- long-term non-healing cracks;
- nonspecific oral ulcers;
- aphthous stomatitis;
- trophic ulcers;
- burn injuries.
The use of Mefenat ointment is prohibited in case of hypersensitivity to it.
In the case of prolonged use, the pharmaceutical drug Mefenat should be used with caution in patients suffering from diseases of the kidneys, blood, and also while taking anticoagulants.
The use of this pharmaceutical product in children is prohibited.
Application during pregnancy and lactation
The efficacy and safety of using the Mefenat pharmaceutical product during the indicated periods have not been studied.
Method of administration and dosage
Mefenat ointment should be applied to damaged areas of mucous membranes or skin with a spatula, a special glass spatula, or using cotton / gauze swabs or napkins one to three times a day.
Aseptic bandage should be applied to the affected skin areas lubricated with this ointment.
The duration of the course of the drug Mefenat is usually from seven to fifteen days. However, if necessary, therapy with this drug can be continued.
To date, cases of ointment overdose have not been described.
During the use of the drug on the damaged mucous membranes of the oral cavity, irritation may occur at the site of its application. They are usually manifested by hyperemia (redness) in the area of application of the ointment, edema, itching, or a burning sensation followed by numbness (mild local anesthetic effect). The above side effects are usually short-lived and disappear on their own.
Storage conditions and periods
Store Mefenat ointment in places protected from light, at a temperature of + 8 ° C … + 15 ° C.
It is necessary to protect the pharmaceutical product Mefenat in places inaccessible to the child.
The shelf life of the drug Mefenat is three years. Do not use the ointment after the expiration date!